Safety Data Sheets for substances and mixtures are sometimes accompanied by exposure scenarios (EN), whose purpose is to describe the optimal operating conditions to be implemented and the risk management measures to ensure the safe use of the substances for a specific use or group of identified uses.
In response to the pandemic, HSE took steps to assist industry’s efforts to increase the availability of hand sanitisers to help reduce the spread/transmission of COVID-19
By July 15, 2022, ECHA is expecting to submit the dossier that is currently under preparation.
On March 16, 2022, Directive (EU) 2022/431 was published in the Official Gazette, amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work.
The Note of 5 April 2022 has been published on the portal of the Ministry of Health, updating the national procedure for the management of applications for authorization of plant protection products for plant health emergencies, in accordance with Article 53 of Regulation EC 1107/2009.
ECHA: published the updated guidance on information requirements for human health related to the Biocidal Products Regulation
Some substances known as endocrine disruptors (EDs) can alter the function(s) of the hormonal system and may cause adverse health effects in humans and wildlife.
According to Regulation 528/2012 the marketing authorization of a biocidal product is issued only if the active substance(s) contained in it has/have been approved for the relevant product type (PT) of interest.
The Biocides mastery division since 2008 has gained considerable experience in the authorization of PMCs, offering to our customers many services.
TEAM mastery has a deep knowledge in the preparation of Applications for Authorisation (AfA) and represents the first Italian company to have successfully presented to ECHA several Authorisation dossiers.